Curcumin targets fibroblast-tumor cell interactions in oral squamous cell carcinoma

Experimental Cell Research

Volumn 319, Issue 6, 2013, Pages 800-809

  Dudás, József ^a   Fullár, Alexandra ^a,b   Romani, Angela ^a   Pritz, Christian ^a   Kovalszky, Ilona ^b   Hans Schartinger, Volker ^a   Mathias Sprinzl, Georg ^a   Riechelmann, Herbert ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Curcuma longa; Head and neck cancer; Polyphenol; Targeting; Tumor microenvironment

Indexed keywords

CD51 ANTIGEN; CURCUMIN; EARLY RESPONSE KINASE; GELATINASE B; I KAPPA B KINASE ALPHA; MESSENGER RNA; PHOSPHOTRANSFERASE; RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CARCINOMA ASSOCIATED FIBROBLAST; CELL INTERACTION; CELL INVASION; CELL MIGRATION; COCULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; FIBROBLAST TUMOR CELL INTERACTION; HYPOTHESIS; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CURCUMA LONGA;

EID: 84875257933     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.12.001     Document Type: Article

References (28)

1. Hanahan D., Coussens L.M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012, 21:309-322.
2. Dudas J., Bitsche M., Schartinger V., Falkeis C., Sprinzl G.M., Riechelmann H. Fibroblasts produce brain-derived neurotrophic factor and induce mesenchymal transition of oral tumor cells. Oral Oncol. 2010, 47:98-103.
3. Dudas J., Fullar A., Bitsche M., Schartinger V., Kovalszky I., Sprinzl G.M., Riechelmann H. Tumor-produced, active Interleukin-1 beta regulates gene expression in carcinoma-associated fibroblasts. Exp. Cell Res. 2011, 317:2222-2229.
4. Dudas J., Bitsche M., Schartinger V., Sprinzl G., Riechelmann H. An in vitro tumor-fibroblast interaction model of human oral squamous cell carcinoma. BMC Proc. 2010, 4:32.
5. Fullar A., Kovalszky I., Bitsche M., Romani A., Schartinger V.H., Sprinzl G.M., Riechelmann H., Dudas J. Tumor cell and carcinoma-associated fibroblast interaction regulates matrix metalloproteinases and their inhibitors in oral squamous cell carcinoma. Exp. Cell Res. 2012, 318:1517-1527.
6. Wilken R., Veena M.S., Wang M.B., Srivatsan E.S. Curcumin: a review of anti-cancer properties and therapeutic activity in head & neck squamous cell carcinoma. Mol. Cancer 2011, 10:12.
7. Chun K.S., Keum Y.S., Han S.S., Song Y.S., Kim S.H., Surh Y.J. Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. Carcinogenesis 2003, 24:1515-1524.
8. Bisht S., Maitra A. Systemic delivery of curcumin: 21st century solutions for an ancient conundrum. Curr. Drug Discov. Technol. 2009, 6:192-199.
9. Gupta N.K., Dixit V.K. Bioavailability enhancement of curcumin by complexation with phosphatidyl choline. J. Pharm. Sci. 2011, 100:1987-1995.
10. Sharma R.A., Euden S.A., Platton S.L., Cooke D.N., Shafayat A., Hewitt H.R., Marczylo T.H., Morgan B., Hemingway D., Plummer S.M., Pirmohamed M., Gescher A.J., Steward W.P. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin. Cancer Res. 2004, 10:6847-6854.
11. LoTempio M.M., Veena M.S., Steele H.L., Ramamurthy B., Ramalingam T.S., Cohen A.N., Chakrabarti R., Srivatsan E.S., Wang M.B. Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin. Cancer Res. 2005, 11:6994-7002.
12. Aggarwal S., Takada Y., Singh S., Myers J.N., Aggarwal B.B. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling. Int. J. Cancer 2004, 111:679-692.
13. Anand P., Sundaram C., Jhurani S., Kunnumakkara A.B., Aggarwal B.B. Curcumin and cancer: an old-age disease with an age-old solution. Cancer Lett. 2008, 267:133-164.
14. Docheva D., Padula D., Popov C., Weishaupt P., Pragert M., Miosge N., Hickel R., Bocker W., Clausen-Schaumann H., Schieker M. Establishment of immortalized periodontal ligament progenitor cell line and its behavioural analysis on smooth and rough titanium surface. Eur. Cell Mater. 2010, 19:228-241.
15. J. Dudas, C. Idler, G. Sprinzl, A. Bernkop-Schnuerch, H. Riechelmann, Identification of HN-1-peptide target in head and neck squamous cell carcinoma cells. ISRN Oncol. 2011 (2011) 140316.
16. Riechelmann H., Deutschle T., Grabow A., Heinzow B., Butte W., Reiter R. Differential response of Mono Mac 6, BEAS-2B, and Jurkat cells to indoor dust. Environ. Health Perspect. 2007, 115:1325-1332.
17. Schartinger V.H., Galvan O., Riechelmann H., Dudas J. Differential responses of fibroblasts, non-neoplastic epithelial cells, and oral carcinoma cells to low-level laser therapy. Support. Care Cancer 2012, 20:523-529.
18. Sun Z.J., Chen G., Zhang W., Hu X., Liu Y., Zhou Q., Zhu L.X., Zhao Y.F. Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-kappaB pathways through a crossed phosphatidylinositol 3-kinase/Akt/IkappaB kinase complex signaling axis in adenoid cystic carcinoma. Mol. Pharmacol. 2011, 79:106-118.
19. Dudas J., Mansuroglu T., Moriconi F., Haller F., Wilting J., Lorf T., Fuzesi L., Ramadori G. Altered regulation of Prox1-gene-expression in liver tumors. BMC Cancer 2008, 8:92.
20. Haller F., Kulle B., Schwager S., Gunawan B., von Heydebreck A., Sultmann H., Fuzesi L. Equivalence test in quantitative reverse transcription polymerase chain reaction: confirmation of reference genes suitable for normalization. Anal. Biochem. 2004, 335:1-9.
21. Franz M., Spiegel K., Umbreit C., Richter P., Codina-Canet C., Berndt A., Altendorf-Hofmann A., Koscielny S., Hyckel P., Kosmehl H., Virtanen I., Berndt A. Expression of Snail is associated with myofibroblast phenotype development in oral squamous cell carcinoma. Histochem. Cell Biol. 2009, 131:651-660.
22. Jiang H.W., Ling J.Q., Gong Q.M. The expression of stromal cell-derived factor 1 (SDF-1) in inflamed human dental pulp. J. Endod. 2008, 34:1351-1354.
23. Dudas J., Ramadori G., Knittel T., Neubauer K., Raddatz D., Egedy K., Kovalszky I. Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: altered potential of hepatocellular carcinoma heparan sulphate. Biochem. J 2000, 350(Part 1):245-251.
24. Baghy K., Dezso K., Laszlo V., Fullar A., Peterfia B., Paku S., Nagy P., Schaff Z., Iozzo R.V., Kovalszky I. Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice. Lab. Invest. 2011, 91:439-451.
25. Tse W.K., Au D.W., Wong C.K. Characterization of ion channel and transporter mRNA expressions in isolated gill chloride and pavement cells of seawater acclimating eels. Biochem. Biophys. Res. Commun. 2006, 346:1181-1190.
26. Mohan R., Sivak J., Ashton P., Russo L.A., Pham B.Q., Kasahara N., Raizman M.B., Fini M.E. Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J. Biol. Chem. 2000, 275:10405-10412.
27. Ray S., Chattopadhyay N., Mitra A., Siddiqi M., Chatterjee A. Curcumin exhibits antimetastatic properties by modulating integrin receptors, collagenase activity, and expression of Nm23 and E-cadherin. J. Environ. Pathol. Toxicol. Oncol. 2003, 22:49-58.
28. Kupferman M.E., Jiffar T., El Naggar A., Yilmaz T., Zhou G., Xie T., Feng L., Wang J., Holsinger F.C., Yu D., Myers J.N. TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma. Oncogene 2010, 29:2047-2059.